Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Efficacy of Pap Test in Combination with ThinPrep Cytological Test in Screening for Cervical Cancer

  • Chen, Hua (Department of Obstetric and gynecology, Gongli hospital) ;
  • Shu, Hui-Min (Department of Obstetric and gynecology, Gongli hospital) ;
  • Chang, Zhou-Lin (Department of Obstetric and gynecology, Gongli hospital) ;
  • Wang, Zhi-Feng (Department of Obstetric and gynecology, Gongli hospital) ;
  • Yao, Hai-Hong (Department of Obstetric and gynecology, Gongli hospital) ;
  • Zhu, Hong-Mei (Department of Obstetric and gynecology, Gongli hospital) ;
  • Lu, Tian-Mei (Department of Obstetric and gynecology, Gongli hospital) ;
  • Ma, Qiang-Yan (Department of Obstetric and gynecology, Gongli hospital) ;
  • Yang, Bin-Lie (Department of Obstetric and gynecology, the people's hospital of the Pudong new area)
  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Our aim was to investigate the efficacy of the Pap test in combination with the ThinPrep cytological test (TCT) in screening for cervical cancer in China. Design: From March 2006 to October 2008, 988 women with the mean age $46.4{\pm}10.5$ years (range, 23-80 years) were recruited to receive cervical cancer screening. Pap test results ${\geq}$ grade III and TCT findings ${\geq}$ ASCUS/AGUS were considered abnormal. Subjects with a Pap test result ${\geq}$ grade IIb received TCT. Colposcopy and biopsies were performed in all participants, and final diagnosis was based on pathological findings. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and Youden index for predicting CIN I or above were determined. Results: The sensitivity, specificity, PPV, NPV and Youden index of the Pap test were 43.1%, 97.2%, 70.0%, 91.9%, and 40.3%, respectively. The same values for TCT in predicting CIN were 80.0%, 63.2%, 16.0%, 97.3%, and 43.2%, respectively. The two tests in combination gave values for predicting CIN of 64.8%, 87.6%, 43.6%, 94.4%, and 53.5%, respectively. Combined testing exhibited the highest Youden index (53.4%). Conclusion: The Pap test with a reduced threshold in combination with the TCT has high sensitivity and high specificity in screening for cervical cancer.

Keywords

References

  1. Abulafia O, Pezzullo JC, Sherer DM (2003). Perfomance of Thinprep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears :a quantitative survey. Gynecol Oncol, 90, 137-44. https://doi.org/10.1016/S0090-8258(03)00176-8
  2. American Cancer Society. Cervical Cancer. 2008. Available at: http://www.cancer.org/acs/groups/cid/documents/webcontent/003094-pdf.
  3. Belinson J, Qiao Y, Pretorius R, et al (1999). Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study. Int J Gynecol Cancer, 9, 411-7. https://doi.org/10.1046/j.1525-1438.1999.99055.x
  4. Belinson J, Qiao YL, Pretorius R, et al (2001). Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol, 83, 439-44. https://doi.org/10.1006/gyno.2001.6370
  5. Belinson JL, Pan QJ, Biscotti C, et al (2002). Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples. Acta Cytol, 46, 470-4. https://doi.org/10.1159/000326863
  6. Bian ML, Chen QY, Liu J, et al (2004). A comparison of cytology and cervicography in cervical cancer screening. J China-Japan Friendship Hospital, 18, 323-52.
  7. Cao ZY (2002). Chinese Obstetrics and Gynecology. 1st ed. Beijing: People's Health Publisher, 1747.
  8. Carns B, Fadare O (2008). Papanicolaou test in the detection of high-grade cervical lesions: a re-evaluation based on cytohistologic non-correlation rates in 356 concurrently obtained samples. Int J Clin Exp Pathol, 1, 285-90.
  9. Fahey MT, Irwig L, Macaskill P (1995). Meta-analysis of Pap test accuracy. Am J Epidemiol, 141, 680-9.
  10. Goldie SJ, Grima D, Kohli M, et al (2003). A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer, 106, 896-904. https://doi.org/10.1002/ijc.11334
  11. Guo M, Hu L, Martin L, et al (2005). Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based test and cervical biopsies on 782 women with previously abnormal Pap smears. Acta Cytol, 49, 55-6.
  12. J, Kang LN, Qiao YL (2011). Review of the cervical cancer disease burden in mainland china. Asian Pac J Cancer Prev, 12, 1149-53.
  13. Li N, Shi JF, Franceschi S, et al (2009). Different cervical cancer screening approaches in a Chinese multicentre study. Br J Cancer, 100, 532-37. https://doi.org/10.1038/sj.bjc.6604840
  14. Ling L, Sun H, Chen W (2004). Role of cervical smear and colposcopy in general gynecological screening. Shanghai J Prevent Med, 16, 351-2.
  15. Pan Q, Belinson JL, Li L, et al (2003). A thin-layer, liquidbased Pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study. Acta Cytol, 47, 45-50. https://doi.org/10.1159/000326474
  16. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Gobal cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  17. Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF (2008). Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J, 50, 419-30. https://doi.org/10.1002/bimj.200710415
  18. Shi JF, Canfell K, Lew JB, et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11, 239.
  19. Shi JF, Canfell K, Lew JB, Qiao YL (2012). The burden of cervical cancer in China: Synthesis of the evidence. Int J Cancer, 130, 6541-2.
  20. Thrall MJ, Pambuccian SE, Stelow EB, et al (2008). Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria. Cancer, 114, 171-9. https://doi.org/10.1002/cncr.23538
  21. Tu JH, Zhong YC, Di W, et al (2008). Value of cervical cytologic tests and colposcopy in diagnosis of cervical lesions. J Shanghai Jiaotong University (Medical Science), 28, 318-31.
  22. Weintraub NT, Violi E, Freedman ML (1987). Cervical cancer screening in women aged 65 and over. J Am Geriatr Soc, 35, 870-5.
  23. Yang L, Parkin DM, Ferlay J, Li L, Chen Y (2005). Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev, 14, 243-50.

Cited by

  1. Diagnosis of 25 genotypes of human papillomaviruses for their physical statuses in cervical precancerous/cancerous lesions: a comparison of E2/E6E7 ratio-based vs. multiple E1-L1/E6E7 ratio-based detection techniques vol.12, pp.1, 2014, https://doi.org/10.1186/s12967-014-0282-2
  2. Incidental Finding of Abnormal Cervical Pathology in Hysterectomy Specimens after Normal Preoperative Papanicolaou Smears in Thammasat University Hospital vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5811
  3. A Systematic Review of Economic Aspects of Cervical Cancer Screening Strategies Worldwide: Discrepancy between Economic Analysis and Policymaking vol.15, pp.19, 2014, https://doi.org/10.7314/APJCP.2014.15.19.8229